Search Articles
WASHINGTON – A federal judge rejected a challenge of delayed regulatory approval for Envarsus DC, an anti-rejection drug Veloxis Pharmaceuticals wants to market for kidney-transplant recipients.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.